SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DNDN - Dendreon Corp. -- Ignore unavailable to you. Want to Upgrade?

To: brk who wrote (125)5/22/2001 4:21:23 PM
From: Elmer  Read Replies (1) | Respond to of 751
 
I'm still long and hope they show positive results in the Phase III trials late this year. If they do, I'll double up. But you were very right to sell when you did. The decline was numbing.

You might also want to wait until results come out. The stock should be worth $30 to $60/share if the results are good. Zero if not.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News